Should our treatment target in MS include the intrathecal plasma cell response?

Gavin Giovannoni, Chris Hawkes, Michael Levy, Jeannette Lechner-Scott, Emmanuelle Waubant

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Pages (from-to)A1-A2
JournalMultiple Sclerosis and Related Disorders
Volume27
DOIs
StatePublished - Jan 1 2019

Keywords

  • Intrathecal oligoclonal IgG response
  • Multiple sclerosis
  • Oligoclonal bands (OCBs)

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this